Lates News

According to AI Fast News of Every Economy, Open Source Securities released a research report on April 8th, giving a "buy" rating to Keqian Biology (688526.SH). The main reasons for the rating include: 1) cost optimization combined with improved gross profit, continuously improving operating quality; 2) continuous increase in research and development investment, accelerated transformation of innovation achievements. (Daily Economic News)